| Full Name | Vipcare |
|---|---|
| Speciality | Clinic/Center |
| Location | 22394 Miflin Rd Ste 104, Foley, Alabama |
| Authorized Official Name and Position | Sriram Sundaramoorthy (CHIEF COMPLIANCE OFFICER) |
| Authorized Official Contact | 8134445838 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Vipcare 601 S Harbour Island Blvd Ste 200 Tampa FL 33602-5925 Ph: (813) 444-5838 | Vipcare 22394 Miflin Rd Ste 104 Foley AL 36535-9593 Ph: (251) 444-1999 |
| NPI Number | 1588446512 |
|---|---|
| Provider Enumeration Date | 10/16/2023 |
| Last Update Date | 03/14/2024 |
| Medicare PECOS PAC ID | 2163879776 |
|---|---|
| Medicare Enrollment ID | O20231103000245 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588446512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Joseph Amato |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417986050 PECOS PAC ID: 5799727582 Enrollment ID: I20050523000399 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Arthur M Williams |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811949753 PECOS PAC ID: 1658307061 Enrollment ID: I20050715000945 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Richard A Bucco |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1518945724 PECOS PAC ID: 7315902210 Enrollment ID: I20060301000353 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Stephen T Simpson |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1013940998 PECOS PAC ID: 4587670112 Enrollment ID: I20060306000569 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Ryan D Rainer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811916620 PECOS PAC ID: 3870503097 Enrollment ID: I20060502000405 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Byron L Nelson |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1487673299 PECOS PAC ID: 4486664604 Enrollment ID: I20060502000417 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Elizabeth M Gilbreath |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477572295 PECOS PAC ID: 9830109073 Enrollment ID: I20060502000629 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Nicholas A Patellis |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366582835 PECOS PAC ID: 3274694864 Enrollment ID: I20100621000383 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Ashley Dan Coleman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1124216551 PECOS PAC ID: 5294916979 Enrollment ID: I20110301000499 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Kathleen B Parks |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457625097 PECOS PAC ID: 1658532015 Enrollment ID: I20120411000350 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | April H Connell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336193549 PECOS PAC ID: 5294746525 Enrollment ID: I20121003000117 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Anthony V Nguyen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396157194 PECOS PAC ID: 8628391018 Enrollment ID: I20171101000824 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Leah Marie Casarez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720571805 PECOS PAC ID: 8921272592 Enrollment ID: I20180628001489 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Robyn Jamese Stiff |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1942649785 PECOS PAC ID: 0042541658 Enrollment ID: I20191014000620 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Richard Gonzales |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386795474 PECOS PAC ID: 7911078357 Enrollment ID: I20210302000815 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
| Provider Name | Katherine Ivy Heffelfinger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780124115 PECOS PAC ID: 0345694261 Enrollment ID: I20230927000477 |
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
News Archive
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.
In support of the ninth annual International Day of Zero Tolerance to Female Genital Mutilation, Melanne Verveer, ambassador-at-large for global women's issues, and David Robinson, acting assistant secretary of state for population, refugees and migration, outline several examples of U.S. advocacy and funding related to stopping the practice of female genital mutilation/cutting (FGM/C) in this post on the State Department's "DipNote" blog.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
› Verified 5 days ago
Gulf Coast Occupational Sports And Pain Medicine Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 222 S Alston St, Foley, AL 36535 Phone: 251-923-2050 Fax: 251-923-2051 | |
Gastroenterologists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1625 N Alston St, Foley, AL 36535 Phone: 251-970-1954 Fax: 251-970-1960 | |
The Dimitri Clinic - Foley Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1506 N Mckenzie St, Suite 106, Foley, AL 36535 Phone: 985-643-4512 Fax: 985-643-4513 | |
Foley Family Practice Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 205 W Orange Ave, Foley, AL 36535 Phone: 251-943-6108 Fax: 251-943-6108 | |
South Baldwin Family Practice Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 202 W Orange Ave, Foley, AL 36535 Phone: 251-943-7237 Fax: 251-943-2451 | |
Alabama Medical Care, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1715 N Bunner St, Foley, AL 36535 Phone: 251-943-2300 Fax: 251-943-2416 | |
Centro Medico Familiar /family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 W Rosetta Ave, Foley, AL 36535 Phone: 251-281-2966 |